Molecular and Physiological Study in Patients with Coronavirus in Thi-Qar Province Iraq

M Obaid Khazaal1, M Çanlı2, E Abdul Kareem Jabbar3

  • 1Ahi Evran University, Kırşehir, Turkey.

Insights

This study found that COVID-19 significantly alters physiological parameters, including decreased hemoglobin and platelets, and increased white blood cells (WBC). These COVID-19 effects varied by gender, impacting blood urea and sugar levels differently.

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Physiology

Background:

  • COVID-19 is a global pandemic with diverse clinical manifestations.
  • Understanding the physiological impact of COVID-19 is crucial for patient management.
  • Previous research indicates potential hematological and biochemical alterations in COVID-19 patients.

Purpose of the Study:

  • To investigate the effects of COVID-19 on key physiological parameters.
  • To assess differences in these parameters based on patient gender and age.
  • To analyze specific biomarkers such as C-reactive protein (CRP), ferritin, and D-dimer.

Main Methods:

  • A cohort of 100 COVID-19 patients and 50 controls were studied.
  • Hematological parameters (hemoglobin, WBC, platelets, lymphocytes) were analyzed.
  • Biochemical markers (blood urea, creatinine, random blood sugar) and inflammatory markers (CRP, ferritin, D-dimer) were measured.
  • Sequencing analysis was performed on isolated viral samples.

Main Results:

  • COVID-19 patients showed significantly lower hemoglobin, lymphocytes, and platelets, but higher white blood cells (WBC) compared to controls.
  • Males exhibited higher hemoglobin, WBC, and platelets, while females had higher lymphocytes.
  • Elevated blood urea, serum creatinine, and random blood sugar were observed in patients. Blood urea was higher in females, and blood sugar in males. Older patients (>70 years) had higher blood urea.
  • CRP, ferritin, and D-dimer levels were significantly elevated in patients, with higher D-dimer in females and higher CRP in the youngest age group.

Conclusions:

  • COVID-19 significantly impacts hematological and biochemical profiles.
  • Gender-specific physiological responses to COVID-19 were observed.
  • Elevated inflammatory markers suggest a systemic inflammatory response in COVID-19 patients.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
294
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
386
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
282
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
219
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
182